China Merchants Securities Co Ltd top stories

News dashboard

  • Venus Medtech prices HK IPO high, nabs $331m

    Venus Medtech (Hangzhou), a Chinese biotechnology company, has wrapped up its Hong Kong IPO at the top end of guidance, raking in HK$2.6bn ($311.1m).

    • 10 Dec 2019
  • JS Global Lifestyle has second go at HK IPO

    JS Global Lifestyle Co, a Hong Kong-based small appliance manufacturer, has started taking orders for its second attempt at a listing, launching bookbuilding on Monday at a fixed price.

    • 09 Dec 2019
  • China Merchants Reit nets $328m from HK IPO

    China Merchants Commercial Real Estate Investment Trust has raised HK$2.6bn ($327.6m) from its IPO, breaking a six-year drought of Reit listings in Hong Kong.

    • 06 Dec 2019
  • CCB’s latest RMBS welcomes record-high international bid

    China Construction Bank, the largest originator of Chinese RMBS, wrapped up a Rmb11.52bn ($1.64bn) four tranche deal on Wednesday. It was just the latest of a regular series of mortgage-backed deals from the bank — but this time, it doubled-down on marketing to foreign investors.

    • 28 Nov 2019
  • Venus Medtech launches $331m Hong Kong IPO roadshow

    Biotechnology company Venus Medtech (Hangzhou) has kicked off bookbuilding for its Hong Kong listing, eyeing a HK$13bn ($1.66bn) valuation.

    • 26 Nov 2019
  • CCB gets S&P on board for latest China RMBS offering

    China Construction Bank, the largest originator in the Chinese RMBS market, is planning to launch a Rmb11.52bn internationally rated four tranche deal next Wednesday. It will include ratings from S&P Global Ratings and, for the first time, its local subsidiary.

    • 21 Nov 2019
  • China Merchants Reit pre-markets $400m HK IPO

    China Merchants Commercial Real Estate Investment Trust has kicked off a pre-deal investor roadshow for its Hong Kong SAR listing. It is set to break a six-year drought of Reit IPOs on the bourse.

    • 14 Nov 2019
  • Venus Medtech preps Hong Kong listing

    Chinese biotechnological company Venus Medtech (Hangzhou) is set to launch its Hong Kong IPO, having lined up an international syndicate to run the deal.

    • 11 Nov 2019
  • Feihe milks investors for HK$6.7bn Hong Kong IPO

    Chinese infant milk formula maker Feihe has raised HK$6.7bn ($856m) from its Hong Kong IPO. Investors put in enough orders to cover the deal by multiple times at the bottom of guidance.

    • 07 Nov 2019
  • Dongfeng Nissan drives home the largest ABS to date

    Dongfeng Nissan Auto Finance bagged Rmb6.5bn ($920m) from its third auto loan ABS trade of the year on Wednesday. Despite being the largest ABS trade the originator has done, the four tranche deal was well covered.

    • 06 Nov 2019

China Merchants Securities Co Ltd In The Key League Tables

Asset Rank STLY Amount $bn No of issues Share % STLY Share %
  • Last updated
  • Today
Bookrunners of Global Structured Finance 16 16 15.27 64 1.45% 1.49%
Bookrunners of Asia-Pac (ex-Japan) ECM 15 15 3.74 26 1.61% 1.80%
Bookrunners of China Domestic DCM 9 6 30.65 148 3.68% 4.47%

All International Bonds

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 JPMorgan 383.74 1789 8.32%
2 Citi 354.85 1533 7.70%
3 BofA Securities 305.97 1325 6.64%
4 Barclays 274.57 1156 5.96%
5 HSBC 225.97 1251 4.90%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 57.61 243 8.24%
2 Credit Agricole CIB 44.80 217 6.40%
3 JPMorgan 35.87 108 5.13%
4 SG Corporate & Investment Banking 31.90 157 4.56%
5 UniCredit 31.50 170 4.50%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 JPMorgan 13.18 83 8.22%
2 Goldman Sachs 12.87 66 8.02%
3 Morgan Stanley 12.21 55 7.61%
4 Citi 10.11 72 6.30%
5 Credit Suisse 6.93 38 4.32%